Articles: 1-10 of 349

Department of Health and Human Services Releases New Provider Relief Fund FAQs: Reporting, Single Audits and What You Can Do Now

USA - October 7 2020 On September 19, 2020, the Health Resources and Services Administration (“HRSA”) of the Department of Health and Human Services (“HHS”) issued…

Maneuvers on the 340B Drug Pricing Program Battlefield: Duplicate Discounts and Contract Pharmacies

USA - September 29 2020 In a December 12, 2017 Advisory Board article, “The 340B drug pricing controversy, explained,” Scott Orwig wrote, “the 340B Drug Pricing Program is…

A Year of Living Dangerously: 2020 and Maneuvers on the 340B Drug Pricing Program Battlefield

USA - September 29 2020 In a December 12, 2017 Advisory Board article, “The 340B drug pricing controversy, explained,” Scott Orwig wrote, “the 340B Drug Pricing Program is…

The Death of RBG…and the ACA?

USA - September 25 2020 The death of Supreme Court Justice Ruth Bader Ginsburg, and alongside it the high probability of a Conservative successor to the open seat she left…

HHS OIG Issues Report Critical of Medicare Advantage Risk Adjustment Practices

USA - September 24 2020 Earlier this month, the U.S. Department of Health and Human Services Office of the Inspector General (the “OIG”) released a report highlighting…

CMS Issues the 2022 Medicare Advantage Advance Notice Part I - Risk Adjustment

USA - September 24 2020 On September 14, 2020, the Centers for Medicare & Medicaid Services (“CMS”) issued the Advance Notice of Methodological Changes for Calendar Year…

The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry

USA - September 17 2020 On Sunday, September 13, 2020, President Trump signed an Executive Order, the next in a series of Executive Orders targeting the pharmaceutical…

Venture Capital And Private Equity Investors Take Note: Primary Care May Be The Next Behavioral Health

OECD, USA - August 5 2020 According to a Centers for Medicare and Medicaid Services (“CMS”) study reported in Health Affairs on March 24, 2020, national health care spending…

A Shot Across the Bow of the Pharmaceutical Industry: President Trump Issues a Quartet of Executive Orders on Drug Pricing that Might Eventually (OR NEVER?) Take Effect

USA - July 27 2020 On Friday, President Trump announced four executive orders directed at decreasing prescription drug prices by ordering certain actions by the…

Reopening Challenges: FAQs On Preparing For Additional Waves Of COVID-19

USA - July 23 2020 Many areas of the country are experiencing resurgences of COVID-19, and it is foreseeable that second and perhaps third waves of the virus will hit…